Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeptune-Calculus Income & Growth Regulatory News (NEP)

  • There is currently no data for NEP

Interim Management Statement

19 May 2009 15:40

RNS Number : 5175S
Neptune-Calculus Income &Growth VCT
19 May 2009
 



Neptune Calculus Income and Growth VCT plc Interim Management Statement

Neptune Calculus Income and Growth VCT plc (the company)

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2009

In accordance with rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Neptune Calculus Income and Growth VCT plc presents an Interim Management Statement for the quarter ended 31 March 2009. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2009

At 31 December 2008

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

 

 

Net assets attributable to shareholders

£3,147,000

 

£6,411,800

£3,196,000

£6,472,000

Shares in issue

4,100,806

8,776,764

4,100,806

8,776,764

Net asset value per share

76.73 pence

73.05 pence

77.94 pence

73.74 pence

Cumulative dividends paid and proposed

8.0 pence

3.9 pence

8.0 pence

3.9 pence

At as 30 April 2009 the net Asset value per Ordinary share was 82.42p and the net asset value per C Ordinary share was 76.50p prior to conversion of the C Ordinary shares to Ordinary shares.

C SHARE CONVERSION

On 30 April 2009 the 8,776,764 C Ordinary shares were converted into 8,300,185 Ordinary shares taking the total number of Ordinary shares in issue to 12,400,991. The net asset value per Ordinary Share on 30 April 2009 following conversion of the C Ordinary shares to Ordinary shares was 81.4p

PERFORMANCE 

In a quarter of continuing difficult economic conditions during which the UK economy contracted by approximately 1.9%, the net asset value per Ordinary Share fell by 1.55% and the net asset value  per C Ordinary share fell by 0.94%. Stock markets were volatile with company valuations remaining depressed.  However there was some good news. In early March, EpiStem Holdings plc in which the company holds 202,063 shares with a book cost of £250,901 signed a major research and development deal with the Swiss drug marker Novartis which will transform Epistem Holdings plc from a Contract Research Services company into a drug development company with secure funding and a much higher revenue potential. The Epistem share price had increased to £2.55 by 31 March 2009 valuing the investment at £515,260 and by 30 April 2009 the share price had risen to £3.50 valuing the investment at £707,221

INVESTMENT ACTIVITY

During the quarter the Company invested a further £120,000 in Managed Support Services PLC as part of a £6million fundraising to provide funds for the management to exploit acquisition opportunities at the depressed stage of the business cycle. There were no disposals or realisations during the period.

SHARE BUY-BACKS

During the quarter ended 31 March 2009 the company did not buy back any shares.

MATERIAL EVENTS

Other than described above, the Board is not aware of any significant event or transaction which has occurred between 31 March 2009 and the date of publication of this Interim Management Statement which would have a material impact on the financial position of the Company. 

For further information please contact:

John Glencross for Neptune Calculus Income and Growth VCT plc: 020 7493 4940

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUUBWAUPBGCB
Date   Source Headline
21st Dec 20062:41 pmRNSVoting Rights and Capital
30th Nov 20065:01 pmRNSCompany Secretary Change
17th Nov 200610:37 amRNSRule 8.3- Aquilo plc
30th Oct 20062:01 pmRNSNet Asset Value(s)
18th Sep 20065:15 pmRNSInterim Results
1st Jun 20065:05 pmRNSResult of Meeting
13th Apr 200612:03 pmRNSAnnual Report and Accounts
7th Apr 20063:03 pmRNSDirector/PDMR Shareholding
6th Apr 20065:14 pmRNSIssue of Equity - Replacement
6th Apr 200612:00 pmRNSIssue of Equity
5th Apr 200611:13 amRNSIssue of Equity
3rd Apr 200612:52 pmRNSNet Asset Value(s)
30th Mar 20063:16 pmRNSIssue of Equity
28th Mar 20062:02 pmRNSFinal Results
22nd Mar 20063:36 pmRNSIssue of Equity
17th Mar 200611:59 amRNSDirector/PDMR Shareholding
15th Mar 20064:31 pmRNSIssue of Equity
17th Nov 200510:20 amRNSHolding(s) in Company
4th Nov 200512:53 pmRNSResult of EGM
6th Oct 20057:00 amRNSPublication of Prospectus
3rd Oct 20054:41 pmRNSNet Asset Value(s)
3rd Oct 200510:40 amRNSIssue of Equity
26th Sep 20055:07 pmRNSInterim Results
15th Sep 200510:47 amRNSChange of Address
30th Aug 20057:01 amRNSUpdate
27th Jun 200512:47 pmRNSAdditional Listing
19th May 20055:03 pmRNSIssue of Equity
5th Apr 20057:49 amRNSIssue of Equity
22nd Mar 20053:51 pmRNSAdditional Listing
14th Mar 200511:42 amRNSUpdate on closing dates
17th Feb 20056:10 pmRNSHolding(s) in Company
7th Feb 20055:01 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.